EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative Evaluation of hiPSC-Derived Brain Organoids as Platforms for Assessing Thyroid Hormone System Disrupting Chemicals

Valeria Fernandez Vallone iD, Lina Hellwig iD, Eddy Rijntjes iD, Nicolai von Kügelgen iD, Rajas Sane, Robert Opitz iD, Peter Kühnen, Josef Köhrle iD, Philipp Mergenthaler iD, Harald Stachelscheid iD

Cells · 22.05.2026 · 15 (11) · 963

DOI: 10.3390/cells15110963 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Cells, online erschienen am 22.05.2026. Verfasst von Valeria Fernandez Vallone und 9 weiteren Autor:innen. Beteiligte Einrichtung: Core Unit Pluripotent Stem Cells and Organoids, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany. Hauptthemen laut MEDLINE: Organoids, Thyroid Hormones, Induced Pluripotent Stem Cells, Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU Horizon 2020 program, Deutsche Forschungsgemeinschaft, Einstein Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thyroid hormones (THs) are essential regulators of human brain development, and disrupted TH availability during pregnancy or early life is linked to adverse neurodevelopmental outcomes. Concerns that environmental chemicals interfere with TH signalling have increased the need for human-relevant in vitro systems to identify thyroid hormone system-disrupting chemicals (THSDCs) for risk assessment. Here, we compared two human-induced pluripotent stem cell (hiPSC)-derived brain organoid models for THSDC assessment: (i) human cortical organoids (COs) generated by unguided differentiation, offering higher architectural complexity but lower throughput; and (ii) neural stem cell-derived organoids (NSCOs), designed for scalability with reduced cellular diversity. Both models expressed key TH handling components, including the transporter SLC16A2 (MCT8) and the inactivating enzyme DIO3. Using LC–MS/MS, we show that exogenous T3 is depleted from culture media and metabolized to 3,3′-T2 and 3′-T1 in both models, alongside upregulation of T3-responsive genes (HR, KLF9, DIO3, SEMA3C). Pulse and chronic co-exposures to reference disruptors iopanoic acid (IA, deiodinase inhibitor) and silychristin (SC, MCT8 inhibitor) altered T3 metabolism and modulated T3-responsive transcriptional endpoints. In NSCOs, high-content imaging revealed treatment-associated changes in cell composition, with chronic T3 reducing the SOX2-positive progenitor pool and THSDCs blocking this effect. Together, these findings provide a framework for organoid qualification—linking TH handling, transcriptomic responsiveness, and scalable phenotypic readouts—as a necessary step toward model validation and implementation of brain organoids in THSDC risk assessment pipelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsThyroid HormonesInduced Pluripotent Stem CellsBrainEndocrine DisruptorsHumansCell DifferentiationNeural Stem CellsIodide Peroxidase

Stichwörter der Autor:innen

NAMsbrain organoidsendpointsthyroid hormone system disruptionvalidation

Substanzen

Thyroid HormonesEndocrine DisruptorsIodide Peroxidase

Autor:innen und Institutionen

  • Core Unit Pluripotent Stem Cells and Organoids, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
  • Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
  • Department of Neurology with Experimental Neurology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
  • Institut für Experimentelle Endokrinologie, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
  • Core Unit Bioinformatics, Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
  • Department for Paediatric Endocrinology and Diabetology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.

ORCID-Profile: Valeria Fernandez Vallone, Lina Hellwig, Eddy Rijntjes, Nicolai von Kügelgen, Robert Opitz, Josef Köhrle, Philipp Mergenthaler, Harald Stachelscheid

Förderung

  • EU Horizon 2020 program
  • Deutsche Forschungsgemeinschaft
  • Einstein Foundation
  • Else Kröner-Fresenius-Stiftung
  • Volkswagen Foundation
  • Charité Foundation
  • Else Kröner-Fresenius Stiftung
  • Volkswagen Stiftung

Zitieren

APA

Fernandez Vallone, V., Hellwig, L., Rijntjes, E., von Kügelgen, N., Sane, R., Opitz, R., Kühnen, P., Köhrle, J., Mergenthaler, P., & Stachelscheid, H. (2026). Comparative Evaluation of hiPSC-Derived Brain Organoids as Platforms for Assessing Thyroid Hormone System Disrupting Chemicals. Cells, 15(11), 963. https://doi.org/10.3390/cells15110963

Vancouver

Fernandez Vallone V, Hellwig L, Rijntjes E, von Kügelgen N, Sane R, Opitz R, et al. Comparative Evaluation of hiPSC-Derived Brain Organoids as Platforms for Assessing Thyroid Hormone System Disrupting Chemicals. Cells. 2026;15(11):963. doi:10.3390/cells15110963

BibTeX
@article{FernandezVallone2026,
  author = {Fernandez Vallone, Valeria and Hellwig, Lina and Rijntjes, Eddy and von Kügelgen, Nicolai and Sane, Rajas and Opitz, Robert and Kühnen, Peter and Köhrle, Josef and Mergenthaler, Philipp and Stachelscheid, Harald},
  title = {Comparative Evaluation of hiPSC-Derived Brain Organoids as Platforms for Assessing Thyroid Hormone System Disrupting Chemicals},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {11},
  pages = {963},
  doi = {10.3390/cells15110963}
}
Kostenlos starten →